Stay in the know with VTCRC news & happenings. Sign up for our email list.

#VTCRCproud – Governor Northam Announces $2.48 Million to Support New Research Commercialization in Emerging Technology Sectors

“These entrepreneurs and innovators are on the front lines of bringing new products and technologies to market, while driving job creation and supporting Virginia’s economic recovery efforts,” said Governor Northam. “I am pleased that the Commonwealth is able to support these growing companies as they develop high-potential solutions in emerging industries and build businesses from research started right here in Virginia.”

“Virginia’s public and private institutions of higher education, tech companies, federal labs, and nonprofit research organizations must have early-stage funding and support to launch and grow their ideas,” said Secretary of Commerce and Trade Brian Ball. “We congratulate the recipients, and I look forward to watching them thrive in the Commonwealth.” 

“Investing in research today is important for the future of Virginia’s technology economy, and these awards pave the way for continued innovation leadership,” said Ed Albrigo, President and CEO of CIT. “These award recipients are advancing a number of new technologies, such as therapeutics, including those for infectious disease; unmanned systems for agriculture, utilities, and smart buildings; and increased cybersecurity for the healthcare industry. We are very proud of our role in helping to bring these innovative solutions to market.”

Press release:

Congratulations to four companies who were recipients and located at the research park!

Li Industries, Inc. | Mr. Nolan Schmidt
Effective Materials Separation for Low-Cost Lithium Ion Battery Direct Recycling, $75,000, Clean Energy, Blacksburg

Eksdyne | Mr. Joshua Eckstein
A Magnetohydrodynamic Actuator System for Robotics, $74,915, Unmanned Systems, Blacksburg

Cowden Technologies, LLC | Mr. Mickey Cowden
Smart Docking Station for Drones, $75,000, Unmanned Systems, Blacksburg

Techulon Inc. | Dr. Nrusingh Mohapatra
PPNA-Based Antimicrobial Therapeutics Against Multi-Drug-Resistant Pseudomonas and Acinetobacter, $75,000, Life Sciences, Blacksburg